Barriers/Facilitators and Care Coordination of Native Hawaiians & Kidney Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Hawaii

About this trial

Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant compared to Whites. They have the highest end-stage kidney disease (ESKD) incidence rates in the nation, begin dialysis at younger ages (30-50 years), and one of the most under-studied racial/ethnic groups in chronic kidney disease (CKD) research. This project's outcome is to improve kidney disease follow-up among early stage NHs at high risk by aligning health equity with a culturally appropriate care coordination systems model.

Eligibility criteria

Qualifiers

greater or equal to 18 years

self-reported as Native Hawaiian

eGFR less than 60 ml/min/1.73m2 (Stage 3a-3b CKD) and/or greater or equal to 30 mg/g UACR

have participated in the NKFH KEDS Program within 3 months

Disqualifiers

None

Trial design

Treatments tested in this trial

  • culturally informed care coordination intervention
  • No Intervention - Usual Care Group

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

1
National Kidney Foundation of Hawaii96822-2214, HonoluluHawaii, United States

Sponsors and collaborators

University of Hawaii

Lead sponsor

National Kidney Foundation, United States

Collaborator